Current outlook on the use of monoclonal antibody therapies for osteoporosis
{{output}}
Introduction: The availability of monoclonal antibody therapies impacting on the basic pathways of bone formation ;(romosozumab) and bone resorption (denosumab) has contributed greatly to our ability to manage patients with osteo... ...
